Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOPAC: Neoadjuvant Gem/Ox vs Adjuvant Gem in Pancreatic Cancer
NCT01521702Phase 3Completed
- Sponsor
- Institut Paoli-Calmettes
- Start
- Dec 2011
- Primary completion
- Feb 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in pancreatic adenocarcinoma (PDAC), sponsored by Institut Paoli-Calmettes. Started Dec 2011; status: completed.
02
Drugs
oxaliplatin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01521702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01521702.